IL-4 and IL-13 are pleiotropic cytokines whose biological activities overlap with each other. IL-13 receptor α chain 1 (IL-13Rα1) is necessary for binding to IL-13, and the heterodimer composed of IL-13Rα1 and IL-4R α chain transduces IL-13 and IL-4 signals; however, the functional mapping of the intracellular domain of IL-13Rα1 is not fully understood. In this study, we constructed wild and mutated types of human IL-13Rα1, and analyzed IL-4 and IL-13 signals using an IL-13Rα1-transfected human B cell line. Expression of IL-13Rα1 evoked STAT3 activation by IL-4 and IL-13, and in stimulated human B cells, on which IL-13Rα1 was highly expressed, IL-4 and IL-13 induced STAT3 activation. Replacement of the two tyrosine residues completely abolished STAT3 activation, although replacing either tyrosine residue alone retained it. Furthermore, we found that the Box1 region and the C-terminal tail of IL-13Rα1 were critical for binding to Tyk2, and activation of Jak1, Tyk2, the insulin receptor substrate-1 and STAT6 respectively. These results suggest that STAT3 activation is involved with IL-4 and IL-13 signals in human B cells along with the activation of STAT6, and that there is a unique sequence in IL-13Rα1 to activate STAT3.
Introduction
IL-13 is a pleiotropic cytokine produced by T h 2-type cells CD23 and MHC class II on B cells, whereas mouse IL-13 does not exert such actions (1). It still remains undetermined and mast cells (1,2). Its biological activities overlap with those of another cytokine, IL-4, and those include anti-inflammatory whether this is because mouse IL-13R is not expressed on mouse B cells or because the machinery for mouse IL-13 is actions on monocytes, production of chemokines and induction of arachidonic acid-metabolizing enzymes on bronchial impaired in mouse B cells. It has been recently shown that IL-13 has a pivotal role in the defense mechanism against epithelial cells. However, IL-4, but not IL-13, induces expansion of T h 2-type cells and proliferation of T cells in both the parasite infection (5,6) and that it is involved in the pathogenesis of bronchial asthma (7-9) in mice. We and others mouse and human systems (1,3,4). IL-4 acts on both mouse and human B cells in the same way, in that it induces class have recently proved that a polymorphism located in the human IL-13 gene is correlated with asthma (10,11). switching including IgE, and expression of CD23 and MHC class II. In contrast, IL-13 behaves on B cells differently in To date, two IL-13-binding units have been identified, the IL-13 receptor α chain 1 (IL-13Rα1) and IL-13Rα2 in both the the mouse and human systems: human IL-13 induces class switching toward IgE and IgG4, as well as expression of mouse and human systems (12) (13) (14) (15) . Both mouse and human IL-13Rα1 have cytoplasmic domains 60 amino acids long, in which the Box1 region and two tyrosine residues exist (Y402 and Y405) (12, 14) . One of the tyrosine residues, Y405, is followed at the ϩ3 position by Gln, which represents a consensus STAT3 recruitment and activation motif (16) . The IL-13R is composed of the heterodimer consisting of IL-13Rα1 and IL-4 receptor α chain (IL-4Rα) (14) . This heterodimer can also transduce IL-4 signals (17, 18) , so it is called type II IL-4R. IL-13Rα2 is assumed to act as a decoy receptor because it has a very short cytoplasmic domain (15) ; however, the details of the function of this molecule remain unclear.
It is known that engagement of the IL-13R by IL-13 induces activation of a variety of signal-transducing molecules (19, 20) . These molecules converge into two pathways: the Jak-STAT pathway and the phosphatidylinositol-3 (PI3) kinase pathway. The former includes activation of Jak1, Jak2 and Tyk2, followed by activation of STAT6 (17, (21) (22) (23) (24) (25) . The latter includes tyrosine phosphorylation of the insulin receptor substrate (IRS)-1/2, followed by activation of PI3-kinase (17, 21, 25, 26) . Analyses of STAT6 knockout mice have verified the necessity of STAT6 for class switching on B cells and expansion of T h 2-type cells induced by IL-4, as well as antiinflammatory actions on monocytes induced by IL-4 and IL-13 (19, 20) . It has been recently demonstrated that expression of mouse IL-13Rα1 induces activation of STAT3, in addition to STAT6 (27) ; however, the necessity for tyrosine residues in STAT3 activation has remained unclear. To date, no study has been reported for human IL-13Rα1.
In this study, we constructed wild and mutated types of human IL-13Rα1, and analyzed IL-13 and IL-4 signals in these types of IL-13Rα1-transfected human B cell line. It turned out that the C-terminal tail of IL-13Rα1 is important for activation of Jak1, Tyk2, IRS-1 and STAT6. We furthermore demonstrated that STAT3 activation by IL-4 and IL-13 occurred when IL-13Rα1 was expressed, which is also the case in primary human B cells. Replacement of either tyrosine residue can still cause STAT3 activation; however, replacement of both tyrosine residues diminished STAT3 activation. These results indicate that there exists a novel signal transduction pathway of IL-13 and IL-4 in human B cells, and that there is a redundancy for requirement of tyrosine residue for STAT3 activation via IL-13Rα1.
Methods

Plasmid construction
Full-length human IL-13Rα1 cDNA was cloned from a cDNA library of HeLa cells, as described before (28) . Three different nucleotides existed between ours and that published before provided by Kyushu University Hospital. Mononuclear cells were separated over Ficoll-Hypaque. B cells were isolated from (14) : T → C at 473, C → T at 833 and A → G at 1157 from the starting point of translation. A survey of nucleotide mononuclear cells with magnetic beads conjugated with anti-CD19 antibody (Dynal, Oslo, Norway). Isolated B cells were sequencing from peripheral blood cells of five healthy Japanese donors showed C, C and G respectively in all cultured in RPMI 1640 medium with 10% FCS, 100 U/ml of penicillin and 100 µg/ml of streptomycin either in the absence samples, so that only T at 883 was replaced with C, using the Kunkel method (29) . A 5Ј-untranslated region (-10 to -1 or presence of 10 µg/ml of anti-IgM antibody (Cappel, Aurora, OH) and 0.5 µg/ml of anti-CD40 antibody (Immunotech, nucleotides), modified to fit the Kozak sequence (GCATGCCGCCATG), as well as the signal sequence (1-84
Marseille, France) for the indicated period.
Harvested cells were stimulated with the indicated connucleotides) of the human IL-4Rα gene, followed by the Flag sequence, were attached to the N-terminus of the corrected centration of IL-4 (provided by Bayer Yakuhin, Kyoto, Japan) or IL-13 (PeproTech, Rocky Hill, NJ) for the indicated period. IL-13Rα1, whose signal sequence (1-63 nucleotides) had been deleted (IL-13Rα1Full; Fig. 1A ). Then this fragment was Flow cytometry incorporated into pIRES1hyg (Clontech, Palo Alto, CA) or pME18S (kindly provided by Dr T. Hara, Tokyo University).
The washed cells were incubated with anti-Flag M2 antibody (Sigma, St Louis, MO), followed by FITC-conjugated antiPlasmids containing two kinds of truncated IL-13Rα1 were constructed by the PCR method using primers conmouse Ig antibody (Zymed, San Francisco, CA). Quantitation was performed using FACScan flow cytometry (Becton taining a stop codon (common: 5Ј-ACGGAAACTCAGCC-ACCTGTG-3Ј, 5Ј-GGAACTCGAGGGAATATAATAATCTAGAGDickinson, San Jose, CA). 3Ј for IL-13Rα1∆CP, 5Ј-ATCATTCTCGAGTCCAAACATTTCLuciferase activity assay TTAA-3Ј for IL-13Rα1∆CT). By this method, the coding regions were terminated at 370 and 385 amino acids from the Procedures of luciferase activity assay were performed as described before (31) . The cells were incubated with the indistarting point of translation of IL-13Rα1. These truncated types of IL-13Rα1 were named IL-13Rα1∆CP and IL-13Rα1∆CT cated concentrations of either IL-4 or IL-13 for 24 h. After the cells were washed once by PBS and lysed with reporter lysis respectively (Fig. 1A) . To replace two tyrosine residues at 402 and 405 amino acids with phenylalanine, we used the PCR buffer (Toyoink, Tokyo, Japan), cell lysates were mixed with luciferase assay reagent (Toyoink). method using the primers 5Ј-GGAAGAAGTTCGACATCTAT-GAGAAGCAAACCAAGGAG-3Ј for IL-13Rα1Y402F, 5Ј-GGImmunoprecipitation and Western blotting AAGAAGTACGACATCTTTGAGAAGCAAACCAAGGAG-3Ј, for IL-13Rα1Y405F and 5Ј-GGAAGAAGTTCGACATCTTTGAProcedures of immunoprecipitation and Western blotting were conducted as previously described (24) . For immuno-GAAGCAAACCAAGGAG-3Ј for IL-13Rα1FF (Fig. 1A) .
The plasmid encoding Tyk2 incorporated to pRK2 was kindly precipitation, the cells were lysed in lysis buffer containing 1 or 0.5% Triton X-100, followed by incubation with the indicated supplied by Dr K. Shimoda (Kyushu University, Fukuoka, Japan).
antibodies. Proteins eluted by boiling with SDS-PAGE sample buffer or cell lysates were applied to SDS-PAGE and transferred Cells and transfection electrophoretically to a PVDF membrane (Amersham, Arlington Heights, IL). Proteins were probed with the indicated antibodies A human B cell line, DND-39, was provided by Hayashibara Biochemical Laboratories (Fujisaki Cell Center, Okayama, and visualized by enhanced chemiluminescence (Amersham). The antibodies used were anti-STAT3, anti-STAT6, anti-Jak1, Japan). DND-39 cells were maintained in RPMI 1640 medium supplemented with 10% FCS, 100 µg/ml streptomycin anti-Jak3, anti-Tyk2 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-phosphotyrosine (PY) (4G10), anti-IRS-1 (Upstate and 100 U/ml penicillin. pGL3-enhancer vector (Promega, Madison, WI) into which the promoter region from -187 to ϩ6
Biotechnology, Lake Placid, NY), anti-phospho STAT3 (New England Biolabs, Beverly, MA) and anti-Flag M2. Anti-STAT5 of human Iε was inserted, and a blasticidin-resisitant gene (Funakoshi, Tokyo, Japan), were co-transfected to DND-39 was kindly provided from Dr H. Wakao (Helix Research Institute, Kisarazu, Japan). cells by electroporation. The resulting stable transfectant was named DND-39/Gε. These cells were maintained in a culture RT-PCR medium containing 6 µg/ml of blasticidin S hydrochloride (Funakoshi). Plasmids containing wild and mutated types Total RNA was extracted from purified human B cells stimulated with 10 µg/ml of anti-IgM antibody and 0.5 µg/ml of anti-CD40 of IL-13Rα1 were transfected to DND-39/Gε cells by electroporation, and stable transfectants were named DND-39/ antibody for the indicated period by Isogen (Nippongene, Tokyo, Japan), and then treated with DNase I (Stratagene, Gε/IL-13Rα1Full, DND-39/Gε/IL-13Rα1∆CP, DND-39/Gε/IL-13Rα1∆CT, DND-39/Gε/IL-13Rα1Y402F, DND-39/Gε/ILLa Jolla, CA) and RNase inhibitor (Roche Diagnostics, Tokyo, Japan). Reverse transcrition was performed using a TaKaRa 13Rα1Y405F and DND-39/Gε/IL-13Rα1FF. These cells were maintained in a culture medium containing 6 µg/ml of blasticidin RNA PCR kit (Takara Shuzo, Otsu, Japan). The competitor for β-actin was constructed with cDNA as S hydrochloride and 250 µg/ml of hygromycin B (Wako, Osaka, Japan). a template using the primers 5Ј-CCTCGCCTTTGCCGAT-CCGTGATGGTGGGCATGGGT-3Ј and 5Ј-ATGAGGTAGTCA-COS7 cells were maintained in DMEM supplemented with 10% FCS, 100 µg/ml streptomycin and 100 U/ml penicillin.
GTCAGGTCCCG-3Ј, corresponding to the portion between -49 and -32 attached to that between ϩ126 and ϩ143 (underProcedures to purify human B cells were described before (30) . Human B cells were isolated from buffy coats lined) and that between ϩ568 and ϩ546 from the starting point of translation respectively. Consequently, the product of the competitor for β-actin was composed of the portion between -49 and -32 attached to that between ϩ126 and ϩ568. The PCR reaction was performed with cDNA as a template using the primers corresponding to the portion between -49 and -32 and that between ϩ568 and ϩ546. This was done in the presence of various amounts of competitors after an initial 5 min denaturation at 94°C, followed by 35 cycles of 94°C for 45 s, 57°C for 45 s and 72°C for 45 s. After the amount of total RNA was normalized based on that of β-actin, the competitive PCR for IL-13Rα1 was performed. The competitor for IL-13Rα1 was constructed with cDNA as a template using the primers 5Ј-CAGTGTAGCACCAATGAGAGTGAG-3Ј and 5Ј-TCAGGTTTC-ACACGGGAAGTTAAAG-3Ј, corresponding to the portion between ϩ301 and ϩ324 and that between ϩ686 and ϩ662 from the starting point of translation respectively. Then the portion between ϩ353 and ϩ404 was cleaved by NsiI. Consequently, the product of the competitor for IL-13Rα1 was composed of the portion between ϩ301 and ϩ352 attached to that between ϩ405 and ϩ686 (334 bp). The PCR reaction was performed with cDNA as a template using the above primers in the presence of various amounts of competitors after an initial 5 min denaturation at 94°C, followed by 45 cycles of 94°C for 45 s, 57°C for 45 s and 72°C for 45 s (386 bp).
Results
Generation of transfectants and expression of the transfected IL-13Rα1
To generate IL-13Rα1-expressing transfectants, we employed a human B cell line, DND-39. Flow cytometry con- the same among the transfectants ( Fig. 2A) . These results FullE5, expressed almost the same level of IL-13Rα1 as DNDclearly indicated that the C-terminal tail of IL-13Rα1 was essen-39/Gε/IL-13Rα1FF (Fig. 1B) . tial for STAT6 activation by IL-13 and affected that by IL-4.
STAT6 activation of the transfectants
As the Iε promoter region contains the binding site for STAT6, we next analyzed the transcription activity of IL-4 and IL-13 It has been confirmed that STAT6 has a pivotal role for IL-4 and on the Iε promoter in the transfectants. The mock-transfected IL-13 signals (19, 20) . To clarify the role of the C-terminal tail of DND-39 cells displayed the transcription activity of IL-4 on the IL-13Rα1 in STAT6 activation, we first analyzed it using four Iε promoter in a dose-dependent manner, but not that of IL-13, kinds of transfectants: mock-transfected DND-39, DND-39/Gε/ whereas DND-39/Gε/IL-13Rα1Full displayed that of both IL-4 IL-13Rα1Full, DND-39/Gε/IL-13Rα1∆CP and DND-39/Gε/ILand IL-13 in a dose-dependent manner (Fig. 2B) . In contrast, 13Rα1∆CT. The mock-transfected DND-39 cells induced tyrosthe transcription activity of IL-4 on the Iε promoter decreased ine phosphorylation of STAT6 by IL-4, but not by IL-13, whereas and that of IL-13 disappeared in both DND-39/Gε/IL-DND-39/Gε/IL-13Rα1Full did so by both IL-4 and IL-13, demon-13Rα1∆CP and DND-39/Gε/IL-13Rα1∆CT, in line with the strating that the transfected IL-13Rα1 transduced the IL-13 results of STAT6 activation (Fig. 2B) . Several clones of each signal ( Fig. 2A) . In contrast, tyrosine phosphorylation of STAT6 by IL-4 declined and that by IL-13 was not detected in either transfectant showed the same tendency (data not shown).
These results suggest that the transcription activity of IL-4 and IL-13 on the Iε promoter parallels the STAT6 activation.
Activation of Jak molecules and tyrosine phosphorylation of IRS-1 of the transfectants
It is widely known that Jak molecules locate upstream of STAT molecules and that activation of Jak molecules is followed by activation of STAT molecules (32, 33) . To elucidate the effect of the C-terminal tail of IL-13Rα1 for STAT6 activation, we next analyzed activation of Jak molecules induced by IL-4 and IL-13 in the transfectants. Jak1 has been shown to be activated by both IL-4 and IL-13, and associate with IL-4Rα upon stimulation of IL-4 (34-37). The mock-transfected DND-39 cells induced tyrosine phosphorylation of Jak1 by IL-4, but not by IL-13, whereas DND-39/Gε/IL-13Rα1Full did so by both IL-4 and IL-13 (Fig. 3A) . In contrast, tyrosine phosphorylation of Jak1 by IL-13 was not detected and that by IL-4 was markedly inhibited in both DND-39/Gε/IL-13Rα1∆CP and DND-39/Gε/IL-13Rα1∆CT (Fig. 3A) . It has been shown that Jak3 constitutively associates with γ c , and is tyrosine phosphorylated upon stimulation of IL-4 (36,38). Activation of Jak3 occurred by IL-4 stimulation in the mock-transfected DND-39 cells and activation of Jak3 by IL-4 was slightly decreased in DND-39/Gε/IL-13Rα1Full or DND-39/ Gε/IL-13Rα1∆CP or DND-39/Gε/IL-13Rα1∆CT, whereas IL-13 did not cause tyrosine phosphorylation of Jak3 in any of the four transfectants (Fig. 3B) . It has been demonstrated that Tyk2 is tyrosine phosphorylated by both human and mouse IL-13 (17, 21, 23, 25) . Activation of Tyk2 was induced by IL-4 and IL-13 only in DND-39/Gε/IL-13Rα1Full; however, it was not induced by IL-4 or IL-13 in the mock-transfected DND-39, DND-39/ Gε/IL-13Rα1∆CP or DND-39/Gε/IL-13Rα1∆CT (Fig. 3C) . The amounts of immunoprecipitated Jak1, Jak3 and Tyk2 were almost the same among the transfectants. (Fig. 3A-C) . Jak2 was also activated as the same manner as Jak1 in the transfectants (data not shown). It has been already shown that stimuli of both IL-4 and IL-13 lead to tyrosine phosphorylation of IRS-1/2, important for recruitment of PI3-kinase to IL-4Rα (20) . To examine the effect of the C-terminal tail of IL-13Rα1 for tyrosine phosphorylation of IRS-1/2, we analyzed tyrosine phosphorylation of IRS-1 and IRS-2 of the transfectants. Neither expression nor tyrosine phosphorylation of IRS-2 by IL-4 or IL-13 was detected in these transfectants (data not shown). The mock-transfected DND-39 cells induced tyrosine phosphorylation of IRS-1 by IL-4, but not by IL-13, whereas DND-39/Gε/IL-13Rα1Full did so by both IL-4 and IL-13 (Fig. 3D) . In contrast, tyrosine phosphorylation of IRS-1 significantly decreased with either IL-4 or IL-13 in both DND-39/Gε/IL-13Rα1∆CP and DND-39/Gε/IL-13Rα1∆CT as well as Jak1 activation (Fig. 3D) , which is compatible with previous reports that IRS-1/2 is a substrate of Jak1 (37, 39, 40) . The amounts of the protein of the applied samples were normalized. Protein staining of the membrane showed that invariable amounts of proteins were applied for each sample (Fig. 3D) . These results suggested that both IL-4 and IL-13 were capable and that the C-terminal tail of IL-13Rα1 was critical. regions of the cytoplasmic domains of the cytokine receptors cDNA was normalized based on that of β-actin, competitive and IL-13Rα1∆CT, but not IL-13Rα1∆CP, was detected and PCR for IL-13Rα1 was performed. The amount of cDNA for stimulation of IL-13 enhanced the association of Tyk2 with IL-13Rα1 started to increase 6 h after stimulation of anti-IgM IL-13Rα1Full, but not IL-13Rα1∆CT (Fig. 4) . The expression antibody and anti-CD40 antibody by~10-fold, and then the levels of Tyk2 and the receptors were invariant (Fig. 4) . These amount reached levels up 100-fold 24 h after the stimulation results demonstrated that the Box1 region in IL-13Rα1 was (Fig. 6A) . Using purified B cells unstimulated and stimulated critical for the association with Tyk2 and that engagement of with anti-IgM antibody and anti-CD40 antibody, we investigated IL-13Rα1 by IL-13 enhanced this association.
whether IL-4 and IL-13 activate STAT3. In the stimulated, but not unstimulated B cells, IL-4 and IL-13 induced tyrosine STAT3 activation in the transfectants phosphorylation of STAT3 by Western blotting (Fig. 6B) . The To explore the possibility that IL-4 and IL-13 induce activation amounts of STAT3 themselves were increased in the stimulated of STAT molecules other than STAT6, we next studied tyrosine B cells, compared to unstimulated B cells (Fig. 6B ). These phosphorylation of STAT molecules induced by either IL-4 or results clearly showed that both IL-4 and IL-13 activated STAT3 IL-13 in the transfectants. Neither expression nor tyrosine in human B cells stimulated with anti-IgM antibody and antiphosphorylation of STAT1, 2 and 4 induced by either IL-4 or CD40 antibody. IL-13 was observed in these transfectants (data not shown).
Expression of STAT5 was detected; however, neither IL-4 nor
Effects of the tyrosine residues of IL-13Rα1 on IL-4 and IL-13 caused tyrosine phosphorylation of STAT5 in these trans-IL-13 signals fectants (Fig. 5A) . In contrast, tyrosine phosphorylation of It is well known that most cytokine receptors are phosphorylated STAT3 was induced by IL-4 and IL-13 only in DND-39/Gε/ILon tyrosine residues by stimuli and it is important for many 13Rα1Full, although it was not evoked by IL-4 or IL-13 in the signal-transducing molecules to be recruited to the receptors mock-transfected DND-39, DND-39/Gε/IL-13Rα1∆CP and (32). IL-13Rα1 possesses two tyrosine residues in the cyto-DND-39/Gε/IL-13Rα1∆CT (Fig. 5B) . The amounts of immunoplasmic portion, at 402 and 405 amino acids. As both of precipitated STAT3 were almost the same among the these tyrosine residues were absent in IL-13Rα1∆CT, it was samples (Fig. 5B) . These results clearly suggest that expresassumed that impairment of the IL-13 signal in DND-39/Gε/ILsion of IL-13Rα1 was required for both IL-4 and IL-13 to activate 13Rα1∆CT is due to the lack of these tyrosine residues, STAT3 and that the C-terminal tail of IL-13Rα1 was essential.
although we could not detect tyrosine phosphorylation of
Activation of STAT3 by IL-4 and IL-13 in stimulated human
IL-13Rα1 (data not shown). Particularly, the sequence around B cells Y405 was compatible with the YXXQ motif, the consensus sequence for binding and activation of STAT3 (16) . To test We next explored the possibility that STAT3 is activated by IL-4 and IL-13, dependent on expression of IL-13Rα1, these possibilities, we investigated the IL-4 and IL-13 signals in It had been controversial whether IL-4 and IL-13 evoke STAT3 activation (23,43-46). Very recently, it was reported that almost the same between DND-39/Gε/IL-13Rα1Full and these three transfectants (Fig. 7A and B) . Tyrosine phosphorylation of expression of mouse IL-13Rα1 in myeloid cell lines led to STAT3 activation by both IL-4 and IL-13 (27) . In this study, we also Tyk2 by IL-4 and IL-13 in DND-39/Gε/IL-13Rα1FF was invariant compared to DND-39/Gε/IL-13Rα1Full (Fig. 7C) . In contrast, demonstrated that expression of human IL-13Rα1 enabled both IL-4 and IL-13 to activate STAT3 using a human B cell line activation of Jak1 by IL-4 was slightly diminished and that by IL-13 was significantly attenuated in DND-39/Gε/IL-13Rα1FF, (Fig. 5) , and in stimulated human B cells, on which IL-13Rα1 was highly expressed, but not unstimulated B cells, both IL-4 whereas it was invariant in DND-39/Gε/IL-13Rα1Y402F and DND-39/Gε/IL-13Rα1Y405F (Fig. 7D) . Activation of IRS-1 by and IL-13 induced STAT3 activation (Fig. 6) . Not only the amounts of IL-13Rα1 mRNA, but also expression of STAT3 IL-13 was also blocked in DND-39/Gε/IL-13Rα1FF as well as Jak1 (data not shown). Furthermore, it is noteworthy that tyroitself, were augmented in stimulated human B cells, compared to unstimulated cells ( Fig. 6A and B) , indicating that the sine phosphorylation of STAT3 induced by either IL-4 or IL-13 completely disappeared in DND-39/Gε/IL-13Rα1FF, although amounts of both IL-13Rα1 and STAT3 regulated STAT3 activation by IL-4 and IL-13 in human primary B cells. IL-4 and IL-13 could activate STAT3 in both DND-39/Gε/IL-13Rα1Y402F and DND-39/Gε/IL-13Rα1Y405F (Fig. 7E) . The Y405 on IL-13Rα1 corresponds to the tyrosine residue of the YXXQ motif, which is the consensus sequence for comparisons with another clone of DND-39/Gε/IL-13Rα1Full, DND-39/Gε/IL-13Rα1FullE5 expressing lower IL-13Rα1 and binding and activation of STAT3 (16) . Our present results-that STAT3 activation by IL-4 and IL-13 was completely blocked in longer exposure of the membranes showed the same results, indicate that these results were not due to relatively lower DND-39/Gε/IL-13Rα1FF, whereas it was induced in DND-39/ Gε/IL-13Rα1Y402F and DND-39/Gε/IL-13Rα1Y405F (Fig. 7) expression of the receptor in DND-39/Gε/IL-13Rα1FF (data not shown). These results suggest that these tyrosine residues suggest that there is a redundancy for the requirement of tyrosine residues for STAT3 activation. Our results were in line were essential for activation of STAT3 and Jak1, but not Tyk2 and STAT6, and that the existence of either tyrosine residue with the previous report that the single replacement of the tyrosine residue at 402 amino acid in mouse IL-13Rα1, corresalone was enough to activate these molecules.
ponding to Y405 in human IL-13Rα1, caused only a partial decrease of STAT3 activation (27) . The mechanism by which Discussion Y402 in IL-13Rα1 is involved in STAT3 activation remains unclear. It has been demonstrated that cysteine can be substiIn this study, we transfected various kinds of human IL-13Rα1 to a human B cell line, and then analyzed activation of Jak tuted for glutamine to generate a STAT3 activation motif (47) ; however, to date, there is no report that the YXXY sequence molecules, IRS-1 and STAT molecules in the transfectants to clarify the functional role of the cytoplasmic domain, particularly could be another STAT3 activation motif. STAT3 has been shown to be activated by various kinds of Jak1 has been shown to be activated by both IL-4 and IL-13, and associate with IL-4Rα upon stimulation of IL-4 cytokines and growth factors (32) , and several target genes of STAT3 have been already identified, such as junB, IRF1, STAT3, (34) (35) (36) (37) . The present results-that tyrosine phosphorylation of Jak1 induced by IL-13 was completely abolished in DND-39/ p19INK4D and c-myc (48-51). The physiological roles of STAT3 in B cells are not fully understood, but it has been shown that Gε/IL-13Rα1∆CT and DND-39/Gε/IL-13Rα1∆CP, and severely impaired in DND-39/Gε/IL-13Rα1FF ( Figs 3A and 7D )-sug-STAT3 is involved in Ig production, an anti-apoptotic effect, and a proliferation effect in B cell lines and myeloma cells (50, 52- gested that IL-13Rα1 was involved in the activation mechanism of Jak1 and that its C-terminal tail, particularly the tyrosine 54), and it is assumed that STAT3 activation is correlated with induction of CD23, ICAM-1 and lymphotoxin-α by engageresidues, was important for the activation. The existence of either tyrosine residue alone was enough for Jak1 activation ment of CD40 in human B cells (55) . To date, the functional role of STAT3 on IL-4 and IL-13 signals in stimulated human B as well as STAT3 activation (Fig. 7D) . Thus far, a mechanism requiring the tyrosine residues of IL-13Rα1 for activation of cells remains to be resolved, whereas that of STAT6 is well investigated (19, 20) . It would be possible that STAT3 and Jak1 remains unknown. It may be important for the binding of shown). The present result-that tyrosine phosphorylation of Jak1 by IL-4 was impaired in DND-39/Gε/IL-13Rα1∆CT and DND-39/Gε/IL-13Rα1∆CP compared to DND-39/Gε mock Abbreviations cells-suggested that competition between IL-13Rα1 and γ c for IL-4Rα occurred (Fig. 3A) receptors containing IL-13Rα1 as a component (Fig. 3C) , in IL-13Rα1Full and IL-13Rα1∆CT, but not IL-13Rα1∆CP, constitu-however, it remained to be resolved whether Tyk2 is also 11 Graves, P. E., Kabesch, M., Halonen, M., Holberg, C. J., Baldini, M., involved in STAT6 activation. The results that activation of STAT6 Fritzsch, C., Weiland, S. K., Erickson, R. P., von Mutius, E. and by IL-13 was retained as well as that of Tyk2 in DND-39/Gε/ILMartinez, F. D. 2000. A cluster of seven tightly linked polymorphisms 13Rα1FF, whereas activation of Jak1 by IL-13 was significantly in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J. Allergy Clin. Immunol. 105:506. blocked in this transfectant (Fig. 7B-D) , strongly supported the blocked, STAT6 activation was not detected (Fig. 2) , suggesting STAT6 induced by IL-13.
